Sano Genetics | Latest News & Updates - Mar 25, 2025 Release
Paul Wicks, Vice President of Neuroscience at Sano Genetics, will host a workshop at THE FIX health-tech festival on September 18, 2025, at Harwell Science Campus in Oxfordshire...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
Sano Genetics
🌎 sanogenetics.comSano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision medicine. The company offers an end-to-end precision medicine platform that integrates genetic testing, recruitment, and long-term patient engagement, streamlining clinical operations and enhancing the efficiency of clinical trials.
Sano Genetics - Latest News and Updates
- Paul Wicks, Vice President of Neuroscience at Sano Genetics, will host a workshop at THE FIX health-tech festival on September 18, 2025, at Harwell Science Campus in Oxfordshire.
- Sano Genetics released a whitepaper exploring breakthroughs and challenges in using gene therapy and precision medicine for hearing loss treatment.
- Paul Wicks, Vice President of Neuroscience at Sano Genetics, is seeking experts to peer review innovative studies.
- Paul Wicks, Vice President of Neuroscience at Sano Genetics, will participate in a panel at HLTH Europe.
- Charlotte Guzzo, COO and co-founder at Sano Genetics, participated in a panel at the Dynamic Leaders event hosted by BDO at Murray Edwards College.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.
